Joseph C. Galante - Apr 14, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Apr 14, 2022
Transactions value $
$1,673
Form type
4
Date filed
5/6/2022, 05:07 PM
Previous filing
Apr 29, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $152 +56 +0.12% $2.71 45.1K Apr 14, 2022 Direct F1
transaction CPIX Common Stock Purchase $147 +56 +0.12% $2.63 45.2K Apr 18, 2022 Direct F1
transaction CPIX Common Stock Purchase $151 +56 +0.12% $2.69 45.2K Apr 19, 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +56 +0.12% $2.74 45.3K Apr 20, 2022 Direct F1
transaction CPIX Common Stock Purchase $154 +56 +0.12% $2.75 45.3K Apr 21, 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +56 +0.12% $2.73 45.4K Apr 22, 2022 Direct F1
transaction CPIX Common Stock Purchase $160 +61 +0.13% $2.62 45.5K Apr 25, 2022 Direct F1
transaction CPIX Common Stock Purchase $154 +61 +0.13% $2.53 45.5K Apr 26, 2022 Direct F1
transaction CPIX Common Stock Purchase $147 +61 +0.13% $2.41 45.6K Apr 27, 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +61 +0.13% $2.51 45.6K Apr 28, 2022 Direct F1
transaction CPIX Common Stock Purchase $149 +61 +0.13% $2.44 45.7K Apr 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.